Redeye leaves a comment on the Q4 report from Egetis Therapeutics released earlier this morning.
Redeye leaves its view on Acarix following the announcement of its year-end report, which overall ca...
Ett fantastiskt år ramas in med en stark avslutning Rapporten för det fjärde kvartalet 2021 var geno...
Idag offentliggjorde Ecoclime resultat för fjärde kvartalet och bokslutet för 2021.
NoHo Partners reported Q4 EBIT of EUR 6.7m, +58% (EUR 2.
Eltel’s Q4 report delivered a clear positive surprise after a disappointing Q3 report.
Solteq’s Q4 was below our lowered pre-Q4 expectations, with revenue at EUR 18.
Aspo’s Q4 adj. EBIT reached EUR 13.9m; we believe ESL’s and Telko’s results are resilient while the ...
A particularly good shipping market was the main reason for Aspo's clear EBIT beat versus market con...
Taaleri reported Q4 EBIT of EUR 14.7m, coming 8% below Refinitiv consensus.
Redeye was surprised by QleanAir’s Q4 report in terms of growth but was left a bit disappointed on t...
Redeye has a positive outlook on IRRAS sales development, but financial burdens are evident in the r...
Redeye's preliminary revisions suggest a small increase in our sales forecast while leaving EBIT lar...
Redeye will only make minor estimate changes on the back of Netmore Group's year-end report.
Redeye provides a comment on Gapwaves' year-end report.
Redeye states that the Q4 report was on the weaker side, but still OK.
Redeye shares its initial take on Stille’s Q4’21 report, which came in slightly below our expectatio...
Redeye is impressed by strong operating margins, which beat expectations.
Waystream reported their Q4 numbers earlier this morning.
Redeye states that the Q4 report was mixed with higher sales but lower profitability negatively impa...
